Supporting patient groups and continuously improving knowledge in our therapy areas is part of our corporate responsibility.
Our ultimate goal is to discover and develop innovative therapies to improve patients' quality of life.
We specialize in the treatment of life-threatening diseases. Our patients always come first.
We offer programs for patients, families and patient organizations worldwide. They help to improve the quality of medical care.
Our product pipeline focuses on innovation and improving therapies.
Welcome to the Research & Development Team in Marburg.
At CSL Behring, we work every day as if someone’s life depends on it, because it does.
CSL Behring's biotherapeutics are manufactured in state-of-the-art facilities under strictly controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
We want you to feel comfortable at CSL.
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
Information for the press, such as press releases and press contact.
Studying under the Eiffel Tower
A semester abroad during my dual studies at CSL Behring.
Australian ambassador visits CSL Behring
CSL Behring management welcomes Australian Ambassador to Germany Philip Green.
COVID-19 Update
CSL continues to provide medicines to patients around the world.
New R&D Campus in Marburg
Video: “Topping-out” milestone celebrated in Marburg for facility scheduled to open in 2022.
Infographic Plasma
From immune system problems to bleeding disorders and more – plasma-based therapies treat many health conditions.
Hemophilia B gene therapy
CSL closes commercialization and license agreement for Hemophilia B gene therapy.
A Network for the Orphans of Medicine
The future of rare disease diagnostics in the focus of science and industry
Donation for “Menschenskinder Marburg e.V.”
Last year’s “Cents for a good cause” will benefit children and young people with mental illnesses.
At the Heart of Innovation for Patients
Marburg, Germany’s vibrant R&D ecosystem creates hope for patients and CSL Behring’s future.
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to ensure the best possible user experience.
Please note that if you do not accept the cookies, your user experience may be significantly less positive.
You will find more information on how to disable the use of cookies in our privacy policy.
